Cargando…
MEDB-41. Identifying a subgroup of patients with early childhood sonic hedgehog-activated medulloblastoma with unfavorable prognosis after treatment with radiation-sparing regimens including intraventricular methotrexate
PURPOSE/METHODS: Clinical and molecular risk factors in 142 patients <5 years with desmoplastic medulloblastoma (DMB) or medulloblastoma with extensive nodularity (MBEN) were investigated. Patients were diagnosed between 1992 and 2020 and treated with radiation-sparing approaches, 131 with intrav...
Autores principales: | Tonn, Svenja, Obrecht, Denise, Sill, Martin, Spohn, Michael, Milde, Till, Pietsch, Torsten, Bison, Brigitte, Juhnke, Björn-Ole, Struve, Nina, Friedrich, Carsten, von Bueren, André O, Gerber, Nicolas U, Benesch, Martin, Jäger, Natalie, Kool, Marcel, Korshunov, Andrey, Schüller, Ulrich, Pfister, Stefan M, Rutkowski, Stefan, Mynarek, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165318/ http://dx.doi.org/10.1093/neuonc/noac079.415 |
Ejemplares similares
-
MEDB-16. Persistent radiological lesions at the end of primary therapy in childhood medulloblastoma: residual lesion or active residual tumor?
por: Schömig, Lena, et al.
Publicado: (2022) -
MEDB-37. Chemotherapy response prediction by molecular risk factors in metastatic childhood medulloblastoma
por: Obrecht, Denise, et al.
Publicado: (2022) -
MEDB-51. Impact of residual tumor on outcomes in children and adolescents with medulloblastoma in the German HIT-cohort
por: Wolgast, Stella, et al.
Publicado: (2022) -
MEDB-50. Assessment of cellular radiosensitivity and DNA repair in medulloblastoma cell lines and patient-derivded xenograft slice cultures
por: Feyerabend, Simon, et al.
Publicado: (2022) -
MEDB-61. Genetic alterations ofTP53 andOTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022)